NEW YORK (GenomeWeb News) — Nanotechnology company Lumera yesterday said it has extended a collaboration with the Medical University of South Carolina to develop a mitochondrial protein-expression array.
 
The agreement grants Lumera the rights to commercialize all jointly developed intellectual property, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.